Retatrutide is a synthetic multi-agonist peptide designed to target several metabolic signaling receptors simultaneously, including GIP, GLP-1, and glucagon pathways in research environments.

Because of this multi-receptor interaction, Retatrutide is increasingly studied for its role in energy balance, metabolic regulation, glucose control models, and nutrient-sensing biochemical pathways.

GENIQ supplies Retatrutide exclusively for laboratory research purposes—not for human or animal administration.